Skip to main navigation Skip to search Skip to main content

Evaluation of diarylureas for activity against plasmodium falciparum

  • Yiqun Zhang
  • , Marc Anderson
  • , Jennifer L. Weisman
  • , Min Lu
  • , Cindy J. Choy
  • , Vincent A. Boyd
  • , Jeanine Price
  • , Martina Sigal
  • , Julie Clark
  • , Michele Connelly
  • , Fangyi Zhu
  • , W. Armand Guiguemde
  • , Cynthia Jeffries
  • , Lei Yang
  • , Andrew Lemoff
  • , Ally P. Liou
  • , Thomas R. Webb
  • , Joseph L. Derisi
  • , R. Kiplin Guy

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

A library of diarylurea insulin-like growth factor 1 receptor inhibitors was screened for activity against chloroquine-sensitive (3D7) and chloroquine-resistant (K1) strains of Plasmodium falciparum. The 4-aminoquinaldine-derived diarylureas displayed promising antimalarial potency. Further exploration of the B ring of 4-aminoquinaldinyl ureas allowed identification of several quinaldin-4-yl ureas 4{13, 39} and 4{13, 58} sufficiently potent against both 3D7 and K1 strains to qualify as bone fide leads.

Original languageEnglish
Pages (from-to)460-465
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume1
Issue number9
DOIs
StatePublished - Dec 9 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Malaria
  • diarylurea

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Evaluation of diarylureas for activity against plasmodium falciparum'. Together they form a unique fingerprint.

Cite this